Overview

Treatment of Primary CNS Lymphoma ( FTD )

Status:
Completed

Trial end date:
2019-03-02

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the efficacy and safety of FTD regiment (fotemustine, temozolomide and dexamethasone ) for patients with primary CNS lymphoma.

Phase:

Phase 2

Details

Lead Sponsor:

Mingzhi Zhang

Collaborator:

Zhengzhou University

Treatments:

Cytarabine
Dexamethasone
Fotemustine
Temozolomide